Olfr771 Inhibitors
Olfr771 is an integral component of the olfactory system in Mus musculus (house mouse), belonging to the extensive family of G-protein-coupled receptors (GPCRs) that are crucial for the sense of smell. This receptor, like other olfactory receptors, is involved in the detection and signaling of odorant molecules. Its unique structural features, including the 7-transmembrane domain typical of GPCRs, enable the specific binding of odorant molecules and the subsequent activation of G proteins. These proteins then initiate a series of intracellular signaling events that ultimately lead to the perception of smell. The functionality of Olfr771 is not only central to olfactory perception but also reflects the broader physiological roles played by GPCRs in various biological processes.
The potential inhibition of Olfr771's function, considering the absence of direct inhibitors, can be achieved through indirect mechanisms by targeting pathways and processes associated with GPCR signaling. The inhibitors listed, including various potassium-sparing diuretics and angiotensin II receptor antagonists, illustrate this approach. For example, diuretics like amiloride and triamterene modulate ion channel activity, which can indirectly affect GPCR signaling by altering cellular ion homeostasis and membrane potential, thereby influencing the function of olfactory receptors. Similarly, angiotensin II receptor antagonists, such as losartan and valsartan, modulate the cardiovascular system and blood pressure control, indirectly affecting GPCR dynamics and potentially impacting olfactory receptor function through systemic signaling modifications. These indirect modes of action underscore the complexity and interconnectedness of cellular signaling pathways, highlighting the potential for modulating sensory perception by targeting ancillary processes that influence GPCR function. Understanding and manipulating these indirect pathways offer valuable insights into the modulation of olfactory receptors and provide a basis for exploring the broader implications of GPCR signaling in physiological and pathological contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride is a potassium-sparing diuretic that inhibits sodium channels. Its modulation of ion channel activity can indirectly influence GPCR signaling, potentially affecting olfactory receptor function through altered ionic balance and membrane potential. | ||||||
Triamterene | 396-01-0 | sc-213103A sc-213103 | 1 g 5 g | $22.00 $54.00 | ||
Triamterene, a potassium-sparing diuretic, inhibits sodium reabsorption. This action can indirectly modulate GPCR signaling pathways, including those of olfactory receptors, by affecting cellular ion homeostasis. | ||||||
Eplerenone | 107724-20-9 | sc-203943 sc-203943A | 10 mg 50 mg | $110.00 $624.00 | 4 | |
Eplerenone is a selective aldosterone receptor antagonist. By inhibiting aldosterone effects, it can indirectly influence GPCR-mediated signaling, potentially impacting olfactory receptor activities through altered sodium and water balance. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone, an aldosterone antagonist, affects sodium and potassium balance. This modulation can indirectly influence GPCR signaling, potentially impacting the function of olfactory receptors through changes in ionic concentrations. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan is an angiotensin II receptor antagonist that impacts GPCR signaling. Its blockade of angiotensin receptors can indirectly influence olfactory GPCR dynamics through crosstalk within the GPCR superfamily. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $40.00 $92.00 $122.00 | 4 | |
Valsartan, an angiotensin II receptor antagonist, influences blood pressure control. This action can indirectly modulate GPCR-mediated signaling pathways, potentially impacting olfactory receptor activities. | ||||||
Olmesartan acid | 144689-24-7 | sc-219481 sc-219481A sc-219481B sc-219481C sc-219481D | 10 mg 500 mg 1 g 2 g 5 g | $156.00 $208.00 $333.00 $533.00 $1072.00 | 7 | |
Olmesartan, an angiotensin II receptor antagonist, is used for managing hypertension. Its action can indirectly influence GPCR signaling, potentially impacting the functionality of olfactory receptors. | ||||||
Irbesartan | 138402-11-6 | sc-218603 sc-218603A | 10 mg 50 mg | $106.00 $303.00 | 3 | |
Irbesartan, an angiotensin II receptor antagonist, modulates cardiovascular function. Its action can indirectly influence GPCR-mediated pathways, including olfactory receptors, by modulating systemic signaling interactions. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $72.00 $94.00 | 8 | |
Telmisartan is an angiotensin II receptor blocker with anti-hypertensive properties. Its blockade of angiotensin receptors can indirectly influence GPCR dynamics, potentially affecting olfactory receptor function. | ||||||
Eprosartan | 133040-01-4 | sc-207631 | 10 mg | $169.00 | 1 | |
Eprosartan is an angiotensin II receptor blocker used in hypertension management. Its action can indirectly influence GPCR-mediated pathways, affecting the activity of olfactory receptors. | ||||||